Plea filed in SC seeking medical panel to look into Covishield risk factors
This development follows AstraZeneca admitting that its COVID-19 vaccine could cause blood clot-related side effects in ‘very rare’ cases.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Chaos
You may also like
Business schools find themselves at a crossroads as the consulting spell breaks
While consulting remains the most sought-after career choice at top B-schools, the sector itself is experiencing its worst downturn in recent history.
Why Nifty 50’s profit is the lowest since COVID-19 pandemic
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.
Why must you choose the right preschool
Preschool education plays a vital role in developing a child’s social and cognitive skills—and isn’t just about play and fun.
